Michael R. Keegan

Dolutegravir-Based Antiretroviral Therapy for Patients Co-Infected with Tuberculosis and Hiv: A Multicenter, Noncomparative, Open-Label, Randomized Trial.

K. Dooley, E. Ticona, O. Sued, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Tryptophan Metabolism and Its Relationship with Depression and Cognitive Impairment Among HIV-infected Individuals

D. Fuchs, A. Winston, R. Ellis, 2016, International journal of tryptophan research : IJTR.

Immune Responses in the Central Nervous System Are Anatomically Segregated in a Non-Human Primate Model of Human Immunodeficiency Virus Infection

D. Fuchs, V. Tsipouri, A. Boasso, 2017, Frontiers in Immunology.

Cerebral function parameters in people with HIV switching integrase inhibitors: a randomized controlled trial

D. Fuchs, A. Winston, S. Khoo, 2021, HIV research & clinical practice.

Tryptophan metabolism and its relationship with central nervous system toxicity in people living with HIV switching from efavirenz to dolutegravir

D. Fuchs, A. Winston, A. Boasso, 2018, Journal of NeuroVirology.

Gibbs Free Energy, a thermodynamic measure of protein-protein interactions, correlates with neurologic disability

H. Siegelmann, E. Rietman, G. Klement, 2019, bioRxiv.

DOLUTEGRAVIR-BASED ANTIRETROVIRAL THERAPY FOR PATIENTS CO-INFECTED WITH TUBERCULOSIS AND HIV: A MULTICENTER, NONCOMPARATIVE, OPEN-LABEL, RANDOMIZED TRIAL

Aboud, K. Dooley, E. Ticona, 2019 .

Gibbs Free Energy, a Thermodynamic Measure of Protein–Protein Interactions, Correlates with Neurologic Disability

H. Siegelmann, E. Rietman, J. Tuszynski, 2021, BioMedInformatics.